Publications and Presentations
Blumenthal RS, Morris PB, Gaudino M, Johnson HM, Anderson TS, Bittner VA, Blankstein R, Brewer LC, Cho L, de Ferranti SD, Gianos E, Gluckman TJ, Gradney KF, Isiadinso I, Lloyd-Jones DM, Marrs JC, Martin SS, McLain KH, Mehta LS, Mora S, Mulugeta WM, Natarajan P, Navar AM, Orringer CE, Polonsky TS, Reynolds HR, Saseen JJ, Shapiro MD, Soffer DE, Tynes SA, Villavaso CD, Virani SS, Wilkins JT. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2026 May 19;87(19):2624-2757.
Writing Committee Members; Blumenthal RS, Morris PB, Gaudino M, Johnson HM, Anderson TS, Bittner VA, Blankstein R, Brewer LC, Cho L, de Ferranti SD, Gianos E, Gluckman TJ, Gradney KF, Isiadinso I, Lloyd-Jones DM, Marrs JC, Martin SS, McLain KH, Mehta LS, Mora S, Mulugeta WM, Natarajan P, Navar AM, Orringer CE, Polonsky TS, Reynolds HR, Saseen JJ, Shapiro MD, Soffer DE, Tynes SA, Villavaso CD, Virani SS, Wilkins JT. 2026
ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2026 Apr 28;153(17):e1154-e1276.
Haas KT, Saseen JJ, Titus O, Lamberton N, Schilling LM, Hogan KN, Marks A, Billups SJ. Blood Pressure Control Among Adherent vs Nonadherent Medicare Patients With Hypertension. Am J Manag Care. 2026 Jul 1;32(7):e228-e233Saseen JJ*, Dixon DL. Nonstatins for LDL-C lowering: An expansion whose time has come. J Clin Lipidol. 2026 Apr 20:S1933-2874(26)00117-0. doi: 10.1016/j.jacl.2026.04.017.
Saseen JJ, Soffer DE. The 2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia-Best evidence and practices aligned. J Clin Lipidol. 2026 Apr 26:S1933-2874(26)00125-X. doi: 10.1016/j.jacl.2026.04.023
Saseen JJ, Soffer DE, Wilkins JT. New Dyslipidemia Guideline Expands Treatment Options and Risk Assessment in Patients With Diabetes and Chronic Kidney Disease. J Am Coll Cardiol. 2026 May 19;87(19):2573-2575.
Olsen KM, Borchert JS, Bookstaver PB, Chahine EB, Connor KA, Cook AM, Dye M, Dull R, Hawkins WA, Adams KK, Doloresco F, Hamada H, Hollis I, Lee HY, Saseen JJ. Importance of Residency Training for the Provision of Comprehensive Clinical Pharmacy Services. J Am Coll Clin Pharm. 2026 Jun;9(6):e70217. doi: 10.1002/jac5.70217.
Ahmad Z, Agarwala A, Cuchel M, Barton Duell P, Hegele RA, Hudgins L, Jamison A, Kalra D, Khera A, Knowles JW, Kullo IJ, Morales A, Rothstein MA, Saseen JJ, Soffer DE, Warden BA, Weintraub WS, Williams L, Goldberg AC. Update on familial hypercholesterolemia: An expert clinical consensus from the National Lipid Association. J Clin Lipidol. 2026 Jan 29:S1933-2874(26)00010-3. doi: 10.1016/j.jacl.2026.01.011. Epub ahead of print. PMID: 41741298.
Bohula EA, Marston NA, Bhatia AK, De Ferrari GM, Leiter LA, Nicolau JC, Park JG, Kuder JF, Murphy SA, Walsh E, Wang H, Blaha V, Budaj A, Cornel JH, Goudev A, Kiss RG, Lorenzatti AJ, Parkhomenko A, Cyrille M, Paiva da Silva Lima G, Ohman EM, Giugliano RP, Sabatine MS; VESALIUS-CV Investigators. Evolocumab in Patients without a Previous Myocardial Infarction or Stroke. N Engl J Med. 2026;394(2):117-127.
Dardouri M, Wright G, Saseen JJ, Nair KV, Anderson KE. Using Prescription Medication Utilization Trends to Evaluate Health System Resilience and Inform Future Emergency Preparedness. J Manag Care Spec Pharm. 2026;32(1):41-52.
